Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first ...
Get the latest news updates and thought-provoking blog posts all in one place
Start Reading βThe FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first ...
Vinted is seeing a structural shift in consumer behaviour as habits form around the resale economy, its marketplace CEO ...
After an Ashes tour dogged by drinking controversies, is an incident in a London nightclub enough to cost Ben Stokes the...
Nvidia challenger D-Matrix is entering full production of an AI chip it says is 10 times faster than a GPU and bypasses ...
It's not the first time the two African giants have gone head-to-head over attacks on their nationals....
The firm, founded in 1809, appointed administrators due to rising energy and labour costs....
The deal marks a bold experiment in the wealth management industry that could shift the balance of power from advisory f...
With a competitive price, winning design, and better performance than the R1, Rivian could be set to break into the big ...
From record representation to Morocco's historic semi-final run, here are six compelling reasons why 2026 could finally ...
Thoma Bravo founder Orlando Bravo says AI offers an "enormous tailwind" for software companies....